Role of EphA4 in Mediating Motor Neuron Death in MND

被引：7

作者：

Zhao, Jing ^{[1
]}

Stevens, Claire H. ^{[2
,3
]}

Boyd, Andrew W. ^{[4
]}

Ooi, Lezanne ^{[2
,3
]}

Bartlett, Perry F. ^{[1
]}

机构：

[1] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia

[2] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia

[3] Univ Wollongong, Sch Chem & Mol Biosci & Mol Horizons, Wollongong, NSW 2522, Australia

[4] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 17期

关键词：

receptors; Eph; EphA4; motor neurons; motor neuron death; neurodegenerative disease; motor neuron disease; pathogenesis; AMYOTROPHIC-LATERAL-SCLEROSIS; IMPROVES FUNCTIONAL RECOVERY; D-ASPARTATE RECEPTORS; RHO-KINASE; D-SERINE; DISEASE; ACTIVATION; INHIBITION; GLUTAMATE; RILUZOLE;

D O I：

10.3390/ijms22179430

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Motor neuron disease (MND) comprises a group of fatal neurodegenerative diseases with no effective cure. As progressive motor neuron cell death is one of pathological characteristics of MND, molecules which protect these cells are attractive therapeutic targets. Accumulating evidence indicates that EphA4 activation is involved in MND pathogenesis, and inhibition of EphA4 improves functional outcomes. However, the underlying mechanism of EphA4's function in MND is unclear. In this review, we first present results to demonstrate that EphA4 signalling acts directly on motor neurons to cause cell death. We then review the three most likely mechanisms underlying this effect.

引用

页数：13

共 50 条

[41] Establishing the UK DNA Bank for motor neuron disease (MND)
Smith, Lucy
Cupid, B. C.
Dickie, B. G. M.
Al-Chalabi, A.
Morrison, K. E.
Shaw, C. E.
Shaw, P. J.
BMC GENETICS, 2015, 16
[42] MORPHOLOGICAL ANALYSES OF THE MOTOR-NEURON DEGENERATION (MND) MOUSE
MAZURKIEWICZ, JE
STROMINGER, NL
MESSER, A
MUSCLE & NERVE, 1986, 9 (05) : 125 - 125
[43] Superconditioning TMS for examining upper motor neuron function in MND
Blair Calancie
Eufrosina Young
Mary Lou Watson
Dongliang Wang
Natalia Alexeeva
Experimental Brain Research, 2019, 237 : 2087 - 2103
[44] Correlates of quality of life in people with motor neuron disease (MND)
Goldstein, LH
Atkins, L
Leigh, PN
AMYOTROPHIC LATERAL SCLEROSIS, 2002, 3 (03): : 123 - 129
[45] Behavioral and electromyographic characterization of mice lacking EphA4 receptors
Akay, Turgay
Acharya, Hernish J.
Fouad, Karim
Pearson, Keir G.
JOURNAL OF NEUROPHYSIOLOGY, 2006, 96 (02) : 642 - 651
[46] EPHA4 Is a Novel Negative Regulator of Collaterogenesis and Vascular Remodeling
Okyere, B.
Hazy, A.
Briclder, T.
Wang, X.
Theus, M.
CELL TRANSPLANTATION, 2016, 25 (04) : 768 - 768
[47] PLASMAPHERESIS IN MOTOR NEURON DISEASE (MND), A CONTROLLED-STUDY
MONSTAD, I
DALE, I
PETLUND, CF
SJAASTAD, O
ACTA NEUROLOGICA SCANDINAVICA, 1978, 57 : 270 - 271
[48] EphA4 Regulates Neuroblast and Astrocyte Organization in a Neurogenic Niche
Todd, Krysti L.
Baker, Kasey L.
Eastman, Matthew B.
Kolling, Frederick W.
Trausch, Alexandra G.
Nelson, Craig E.
Conover, Joanne C.
JOURNAL OF NEUROSCIENCE, 2017, 37 (12): : 3331 - 3341
[49] EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
Nikas, Ilias
Giaginis, Constantinos
Petrouska, Kalliopi
Alexandrou, Paraskevi
Michail, Artemis
Sarantis, Panagiotis
Tsourouflis, Gerasimos
Danas, Eugene
Pergaris, Alexandros
Politis, Panagiotis K.
Nakopoulou, Lydia
Theocharis, Stamatios
DIAGNOSTICS, 2022, 12 (02)
[50] CSF VASOPRESSIN AND OXYTOCIN IN MOTOR-NEURON DISEASE (MND)
SECKL, JR
LIGHTMAN, SL
GUILOFF, RJ
CLINICAL SCIENCE, 1987, 72 : P63 - P63

← 1 2 3 4 5 →